Cargando…
Les anticorps monoclonaux anti-SARS-CoV-2, une opportunité à saisir()()
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Masson SAS on behalf of l'Académie nationale de médecine.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901267/ https://www.ncbi.nlm.nih.gov/pubmed/33642596 http://dx.doi.org/10.1016/j.banm.2021.02.021 |
| _version_ | 1783654361275039744 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7901267 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Masson SAS on behalf of l'Académie nationale de médecine. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79012672021-02-24 Les anticorps monoclonaux anti-SARS-CoV-2, une opportunité à saisir()() Bull Acad Natl Med Coronavirus : avis de l’Académie nationale de médecine Published by Elsevier Masson SAS on behalf of l'Académie nationale de médecine. 2021-05 2021-02-23 /pmc/articles/PMC7901267/ /pubmed/33642596 http://dx.doi.org/10.1016/j.banm.2021.02.021 Text en © 2021 Published by Elsevier Masson SAS on behalf of l'Académie nationale de médecine. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Coronavirus : avis de l’Académie nationale de médecine Les anticorps monoclonaux anti-SARS-CoV-2, une opportunité à saisir()() |
| title | Les anticorps monoclonaux anti-SARS-CoV-2, une opportunité à saisir()() |
| title_full | Les anticorps monoclonaux anti-SARS-CoV-2, une opportunité à saisir()() |
| title_fullStr | Les anticorps monoclonaux anti-SARS-CoV-2, une opportunité à saisir()() |
| title_full_unstemmed | Les anticorps monoclonaux anti-SARS-CoV-2, une opportunité à saisir()() |
| title_short | Les anticorps monoclonaux anti-SARS-CoV-2, une opportunité à saisir()() |
| title_sort | les anticorps monoclonaux anti-sars-cov-2, une opportunité à saisir()() |
| topic | Coronavirus : avis de l’Académie nationale de médecine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901267/ https://www.ncbi.nlm.nih.gov/pubmed/33642596 http://dx.doi.org/10.1016/j.banm.2021.02.021 |